| Dr Liyen L Sun, DDS | |
|
25835 Narbonne Ave, Ste. 265, Lomita, CA 90717-3074 | |
| (310) 325-8600 | |
| Not Available |
| Full Name | Dr Liyen L Sun |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 25835 Narbonne Ave, Lomita, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720104797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 28888 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Liyen L Sun, DDS 25835 Narbonne Ave, Ste. 265, Lomita, CA 90717-3074 Ph: (310) 325-8600 | Dr Liyen L Sun, DDS 25835 Narbonne Ave, Ste. 265, Lomita, CA 90717-3074 Ph: (310) 325-8600 |
News Archive
A study presented today at the International Liver CongressTM 2013 - which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk score (FRS) - showed that NAFLD increases the risk of early atherosclerotic lesions independent of established cardiovascular (CV) risk factors.
Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free survival and overall survival, according to a study in the March 28 issue of JAMA.
Portuguese researchers have discovered a "broad spectrum" cancer suppressor gene - called LRP1B - which acts by removing proteins crucial for cancer development from the tumour environment. The fact that LRP1B does not act on the tumour itself (in this study thyroid tumours) but, instead, on molecules which are known to be important to many different cancers is what makes it so interesting.
Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from pivotal phase 3 studies of azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB), demonstrating greater 24-hour systolic blood pressure (SBP) reduction compared to commonly prescribed ARBs olmesartan medoxomil and valsartan.
› Verified 1 days ago
David Sasha Ganji, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1834 Pacific Coast Hwy, Lomita, CA 90717 Phone: 310-326-5183 | |
Dr. Kayvon Javid, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2104 Pch #5, Lomita, CA 90717 Phone: 310-539-1111 Fax: 310-539-4111 | |
Mrs. Misung Paik, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1816 Lomita Blvd, Lomita, CA 90717 Phone: 310-326-4117 Fax: 310-326-0081 | |
Dr. Louis Lin, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 2146 W Lomita Blvd, Lomita, CA 90717 Phone: 310-326-6668 Fax: 310-326-6669 | |
Dr. Narinder P. Uppal, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 25107 Narbonne Ave, Lomita, CA 90717 Phone: 310-539-8392 Fax: 310-539-5605 | |
Dr. Leo Jireh Cioco Abelita, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1809 1/2 West Lomita Boulevard, Lomita, CA 90717 Phone: 310-539-1224 Fax: 310-530-5796 | |
Dr. Carlos Limasin Ilem, D.M.D.,PC. Dentist Medicare: Not Enrolled in Medicare Practice Location: 24205 Narbonne Ave Ste 201, Lomita, CA 90717 Phone: 310-534-0373 |